|
|
News
Click here for the ACPE Update Newsletter!
Update on Recognition of CCAPP Accreditation Decisions
Download Adobe Acrobat File
Previous Report of Proceedings, June 2009
Download Adobe Acrobat File
Current Report of Proceedings, January 2010
Download Adobe Acrobate File
ACPE REPORT OF PROCEEDINGS
January 20-24, 2010 I.Election of ACPE Officers for 2010-2011
Officers for the January 25, 2010 – January 23, 2011 year, elected by a unanimous vote of the ACPE Board of Directors during the January 20-24, 2010 meeting, are as follows: President – Heidi M. Anderson, PhD, Associate Provost for Faculty Affairs, University of Kentucky; Vice President – Robert S. Beardsley, RPh, PhD, Professor, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy; Secretary-Treasurer – Michael A Moné, RPh, JD, FAPhA, Vice President Anti-Diversion & Supply, Chain Integrity & Sr., Regulatory Counsel, Healthcare Supply Chain Services, Cardinal Health. Outgoing officers: President William A. Gouveia, MS, FASHP, Adjunct Clinical Professor, School of Pharmacy, Northeastern University, Boston, MA; and Secretary-Treasurer – Donald H. Williams, RPh, FASHP, retired Executive Director, Washington State Board of Pharmacy. Gouveia and Williams were thanked for their meritorious service as officers of ACPE.
II.Public Interest Panel Review of Professional Degree Programs
The ACPE Public Interest Panel met on January 11, 2010, to discuss the professional programs scheduled for review by the ACPE Board of Directors during its January 20-24, 2010. Evaluation team reports and other materials associated with the evaluation of the professional degree programs were duly considered. The Board considered the comments and recommendations of the Panel. Panel members who attended the meeting were: Erin Keyser Norton, James Hall and Michael A. Diamond.
III.Strategic Planning
The 2009 Strategic Plan was discussed and actions addressed by the Board and staff on January 23-24, 2010.
IV.Accreditation Actions for Professional Degree Programs, taken at the ACPE Board of Directors Meeting, January 20-24, 2010
A list of accredited professional degree programs of colleges and schools of pharmacy, which designates the respective accreditation status of the programs and the academic year for the next currently scheduled evaluation, is posted on the ACPE web site at www.acpe-accredit.org
Accreditation Actions
On the basis of self-studies, on-site evaluations, communications received from the institutions, ongoing review of North American Pharmacist Licensure Examination (NAPLEX) passing rates and entry class size, and the comments of the Public Interest Panel, the Board of Directors determined the accreditation status of the following professional programs, along with accreditation terms and conditions.
In order to be eligible for initial or continuing accreditation, the Doctor of Pharmacy program must be part of an independent College or School of Pharmacy or a College or School of Pharmacy within a University, which is regularly incorporated and is a legally empowered postsecondary educational institution. The institution housing the College or School, or the independent College or School, must be accredited by a regional/institutional accreditation agency recognized by the U.S. Department of Education or another agency acceptable to the Accreditation Council for Pharmacy Education (ACPE). Accreditation standards call for a College or School of Pharmacy as an organizational unit and the administrative structure of the College or School of Pharmacy must provide for a Dean, who serves as the chief administrative and academic officer. Evaluation for purposes of initial or continued accreditation requires an invitation by the chief executive officer, or designate, of the institution.
An action to “affirm” implies that a previously established accreditation term has been confirmed. An action to “continue” implies that the accreditation date has been extended. The customary cycle of review for established accredited programs is six years, while the customary review cycle for new programs achieving initial accreditation status is two years. The dates indicated in parentheses for each College or School are the academic year of the most recent determination of accreditation status and the academic year of the next scheduled determination of accreditation status, and thus define the present accreditation term for the Doctor of Pharmacy program.
The accreditation actions are as follows:
For Purposes of Considering Continued Accreditation Status
Campbell University School of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
Lebanese American University School of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2011-2012)
Massachusetts College of Pharmacy and Health Sciences School of Pharmacy –Worcester
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2011-2012)
Northeastern University Bouvč College of Pharmacy and health Sciences School of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
Ohio Northern University College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
University of Colorado-Denver School of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2011-2012)
University of Kentucky College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
University of Minnesota College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
University of New Mexico College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
University of Pittsburgh School of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
University of Rhode Island College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
University of Southern Nevada College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
Wayne State University Eugene Applebaum College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2015-2016)
For Purposes of Consideration of Advancement from Precandidate Accreditation Status to Candidate Accreditation Status
California Northstate College of Pharmacy Doctor of Pharmacy Program:
Candidate status was granted. (2008-2009; 2011-2012)
For Purposes of Consideration of Advancement from Precandidate Accreditation Status to Candidate Accreditation Status
Concordia University School of Pharmacy
Doctor of Pharmacy Program: precandidate status was granted. (2009-2010; 2010-2011)
D’Youville College School of Pharmacy
Doctor of Pharmacy Program: precandidate status was granted. (2009-2010; 2010-2011)
Presbyterian College School of Pharmacy
Doctor of Pharmacy Program: precandidate status was granted. (2009-2010; 2010-2011)
University of Maryland Eastern Shore School of Pharmacy and Health Sciences
Doctor of Pharmacy Program: precandidate status was granted. (2009-2010; 2010-2011)
For Purposes of Consideration of Advancement from Precandidate Accreditation Status to Candidate Accreditation Status
Appalachian College of Pharmacy
Doctor of Pharmacy Program: full accreditation was granted. (2009-2010; 2011-2012)
New School Applications: For Purposes of Consideration of Authorization of On-site Evaluations
Philadelphia College of Osteopathic Medicine School of Pharmacy
An on-site evaluation was authorized to be conducted during spring 2010, so as to provide the basis for the Board’s consideration of precandidate accreditation of the Doctor of Pharmacy program at its June 2010 meeting.
St. Joseph College School of Pharmacy
An on-site evaluation was authorized to be conducted during spring 2010, so as to provide the basis for the Board’s consideration of precandidate accreditation of the Doctor of Pharmacy program at its June 2010 meeting.
Tri-State College of Pharmacy
An on-site evaluation was not authorized. The institution was advised to submit a revised application.
Monitoring During the Accreditation Period
Interim Reports
Interim reports for the Doctor of Pharmacy programs of the following colleges/schools were reviewed. If additional on-site monitoring has been requested through a focused visit, this is indicated by an asterisk and the proposed date is noted.
Auburn University Harrison School of Pharmacy (2005-2006; 2011-2012)
Butler University College of Pharmacy and Health Sciences (2007-2008; 2011-2012)
Creighton University School of Pharmacy and Health Professions (2005-2006; 2011-2012)
Ferris State University College of Pharmacy (2004-2005; 2010-2011)
Lipscomb University College of Pharmacy (2008-2009; 2010-2011)
Midwestern University Chicago College of Pharmacy (2006-2007; 2012-2013)
Ohio State University College of Pharmacy (2004-2005; 2010-2011)
Oregon State University College of Pharmacy (2007-2008; 2011-2012)
Palm Beach Atlantic University Lloyd L. Gregory School of Pharmacy (2008-2009; 2010-2011)
Purdue University College of Pharmacy, Nursing, and Health Sciences (2005-2006; 2011-2012)
Samford University McWhorter School of Pharmacy (2004-2005; 2010-2011)
South Dakota State University College of Pharmacy (2008-2009; 2014-2015)
Temple University School of Pharmacy (2004-2005; 2010-2011)
Touro New York College of Pharmacy (2008-2009; 2010-2011)
University at Buffalo, School of Pharmacy and Pharmaceutical Sciences (2005-2006; 2011-2012)
University of California San Francisco School of Pharmacy (2007-2008; 2013-2014)
University of Cincinnati James L. Winkle College of Pharmacy (2006-2007; 2012-2013)
University of Houston College of Pharmacy (2004-2005; 2010-2011)
University of Iowa College of Pharmacy (2003-2004; 2010-2011)
University of Louisiana at Monroe College of Pharmacy (2007-2008; 2013-2014)
University of Mississippi School of Pharmacy (2005-2006; 2011-2012)
University of Montana Skaggs School of Pharmacy (2005-2006; 2011-2012)
University of Oklahoma College of Pharmacy (2005-2006; 2011-2012)
University of North Carolina at Chapel Hill Eshelman School of Pharmacy (2005-2006; 2011-2012)
University of Puerto Rico Medical Sciences Campus School of Pharmacy (2006-2007; 2010-2011)
University of Tennessee College of Pharmacy (2008-2009; 2014-2015)
University of Wisconsin-Madison School of Pharmacy (2005-2006; 2011-2012)
University of Wyoming School of Pharmacy (2006-2007; 2012-2013)
Virginia Commonwealth University School of Pharmacy (2008-2009; 2014-2015)
Wilkes University The Nesbitt College of Pharmacy and Nursing School of Pharmacy (2008-2009; 2010-2011)
Wingate University School of Pharmacy (2008-2009; 2012-2013)
Review of Programs with Substantive Change and other requests
Substantive change notifications from the following colleges/schools were received (action, if any, noted in bold and parentheses): Campbell University School of Pharmacy; Chicago State University College of Pharmacy; and University of Illinois at Chicago College of Pharmacy
Focused On-site Evaluation Visits
Board and Staff focused on-site evaluation visits are authorized when the Board is desirous of additional on-site monitoring to evaluate various programmatic issues. An action to “affirm” implies that a previously established accreditation term has been confirmed. An action to “continue” implies that the accreditation date has been extended, usually to reestablish the customary six-year cycle.
Albany College of Pharmacy and Health Sciences
Doctor of Pharmacy Program: accreditation was affirmed. (2004-2005; 2010-2011)
Florida A&M University College of Pharmacy and Pharmaceutical Sciences
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2012-2013)
South University College of Pharmacy
Doctor of Pharmacy Program: accreditation was affirmed. (2008-2009; 2011-2012)
Texas Southern University College of Pharmacy
Doctor of Pharmacy Program: accreditation was continued. (2009-2010; 2011-2012)
V.Accreditation Actions for Providers of Continuing Pharmacy Education
ACPE Board of Directors accepted the report of the ACPE Continuing Pharmacy Education Commission at the January 2010 meeting.
Accreditation of New Applications
Organizations seeking ACPE-accredited provider status are asked to submit an Application for Initial Accreditation. This application asks questions regarding the applicant’s experience relative to areas addressed by ACPE’s Standards for Continuing Pharmacy Education. Initial terms of accreditation are usually for two years with a First Review in one year, fall 2010, and a Second Review, fall 2011, in two years.
Four applications for Initial Accreditation were reviewed and accredited: David Begg Associates, LLC; Humana, Inc.; Palm Beach Atlantic University; and Sullivan University College of Pharmacy
One application for Initial Accreditation was reviewed and not accredited: Cigna Tel-Drug
Submission of First Review by Applicants Initially Accredited in Fall 2008
Seven applicants submitted first reviews (next review date is included in parentheses), including:
Gannett Education (fall 2010); Gateway International, LLC (fall 2010); Karmanos Cancer Center (fall 2010); MedEDirect, LLC (fall 2010); Memorial Hermann (fall 2010); Southeastern Continuing Medical Education Consultants, LLC (fall 2010); and Union University School of Pharmacy (fall 2010)
Submission of Second Review by Applicants Initially Accredited in Fall 2007
Eight applicants submitted second reviews (next review date is included in parentheses), including:
Cook Children's Medical Center (fall 2013); Cross Country Education, LLC (fall 2013); Institute for Brain Potential (fall 2013); Institute for Post Graduate Continuing Education (fall 2013); Mad ID, Inc. (fall 2013); Primary Care Education Consortium (fall 2013); Select CE (fall 2013); and University Health System Department of Pharmacy (fall 2013)
Consideration for Continued Accreditation on the Basis of Comprehensive Reviews
The submitted Self-Assessment Report undergoes both a Commissioner review, an internal (ACPE staff) review, an external (Field reviewer) review, a review of all records including correspondence, Activity Description Forms (ADFs), if any, a conference call with the provider and the reviewers, complaints and third party comments. The Comprehensive Review for Continued Accreditation provides the basis for the Council’s action to continue the provider’s term of accreditation. The standard term of accreditation is six years.
Comprehensive Reviews from twelve providers were considered and acted upon. The next Comprehensive Review for the following is fall 2015 and they include:
American Society of Health-System Pharmacists; Emory University Hospital Department of Pharmaceutical Services; Medical Education Resources, Inc.; New York Presbyterian Hospital Department of Pharmacy; Northeastern University Bouve College of Health Sciences School of Pharmacy; Philadelphia College of Pharmacy; South Dakota State University College of Pharmacy; National Pharmacy Technician Association (NPTA); University of Georgia College of Pharmacy; University of Mississippi School of Pharmacy; University of the Pacific, Thomas J. Long School of Pharmacy and Health Sciences; and W-F Professional Associates, Inc.
The reviews of the following six Comprehensive Reviews resulted in shortened terms (Progress Report fall 2010);
The CE Solution, Inc.; The Center for Professional Advancement; Lehigh Valley Hospital Pharmacy Department; The Medical Letter, Inc.; Michigan Pharmacists Association; and University of Houston College of Pharmacy.
Consideration for Continued Accreditation on the Basis of Progress Reports
Providers who have a shortened term of accreditation of one year are asked to submit a Progress Report. A Progress Report addresses only those issues that remain a concern following the previous Comprehensive Review or Interim Report. However, because the provider has been given a shortened term of accreditation, the Progress Report, like the Comprehensive Review, serves as the basis for the Board to act to continue recognition as an accredited provider.
Progress reports submitted by twelve providers were considered and acted upon by the Board. They are (next review date is included in parentheses):
American Association of Diabetes Educators (fall 2014); Bayfront Medical Center (fall 2014); Cine-Med, Inc. (spring 2011); European Association of Hospital Pharmacists (EAHP) (fall 2013); George Washington University Hospital Department of Pharmacy (fall 2014); Lee Memorial Health System (fall 2014); Missouri Pharmacy Association (fall 2014); National Community Pharmacists Association (fall 2013); Nebraska Council for Continuing Pharmaceutical Education, Inc. (fall 2014); New Jersey Pharmacists Association (fall 2014); The Ohio State University College of Pharmacy (fall 2012); and Rutgers University Ernest Mario School of Pharmacy (fall 2014)
The review of the following Progress Report resulted in a shortened term. It is (next review date is included in parentheses):
University of Texas - El Paso (fall 2010)
Consideration for Continued Accreditation on the Basis of Interim Reports
All providers with a standard term of accreditation of six years are asked to submit an Interim Report, usually in two or three years. The Interim Report serves as an update on specific issues that were identified in the provider’s Comprehensive Review. Actions include affirm status and terms and determine additional reporting as needed or modify previously established terms and determine new reporting requirements. Interim reports submitted by fifty four providers were considered and acted upon by the Board. They included (next Comprehensive Review date is included in parentheses):
Alabama Pharmacy Association Research & Education Foundation (fall 2013); Alabama Society of Health-System Pharmacists (spring 2013); Alaska Pharmacists Association (fall 2012); Albany College of Pharmacy (spring 2012); Albertson's, Inc. (fall 2013); American Society for Clinical Pharmacology and Therapeutics (fall 2012); American Society for Parenteral and Enteral Nutrition, Inc. (fall 2014); Auburn University Harrison School of Pharmacy (fall 2013); Barnett International (fall 2013); CMEsolutions (fall 2013); Comprehensive Pharmacy Services, Inc. (fall 2010); education | outcomes | science (fall 2012); Fisher BioServices, Inc. (spring 2012); Florida Pharmacy Association (fall 2014); Health Insights (fall 2010); Hematology/Oncology Pharmacy Association (HOPA) (fall 2012); Henry Ford Health System (fall 2013); Institute for Healthcare Improvement (fall 2013); Institute for Natural Resources (INR) (fall 2014); King's Daughters' Medical Center (fall 2014); LearnSomething, Inc. (fall 2014); Louisiana State University Health Sciences Center-Shreveport (fall 2012); Minnesota Pharmacists Association (fall 2010); NACDS Foundation (spring 2013); National Association of Boards of Pharmacy and NABP Foundation, Inc. (fall 2013); New York State Council of Health-System Pharmacists (fall 2013); Oregon State University (fall 2011); Penn State Milton S. Hershey Medical Center (fall 2014); PharmaCE (fall 2013); Pharmaceutical Education & Research Institute, Inc. (PERI) (fall 2012); Pharmacy Society of Wisconsin (fall 2013); Pharmacy Times Office of Continuing Professional Education (spring 2014); PharmCon, Inc. (fall 2013); Purdue University School of Pharmacy and Pharmaceutical Sciences (fall 2012); Quest Educational Services, Inc. (fall 2011); Saudi Pharmaceutical Society c/o King Saud University College of Pharmacy (fall 2012); Society of Critical Care Medicine (spring 2015); South Carolina Pharmacy Association (fall 2012); Stony Brook University Medical Center (fall 2012); Syntaxx Communications, Inc. (fall 2014); Texas Pharmacy Association (spring 2013); Tufts University School of Medicine, Office of Continuing Education (fall 2012); University of Findlay School of Pharmacy (fall 2011); University of Kansas School of Pharmacy (fall 2012); University of Michigan College of Pharmacy (fall 2014); University of Rhode Island College of Pharmacy (fall 2014); Utah Pharmacists Association (fall 2013); Vanderbilt University Hospital Department of Pharmaceutical Services (fall 2012); Virginia Pharmaceutical Association (fall 2013); Walgreens Health Initiatives (fall 2012); Washington Hospital Center (fall 2014); William Beaumont Hospital Department of Pharmaceutical Services (fall 2013); Wingate University School of Pharmacy (fall 2010); and Xavier University of Louisiana College of Pharmacy (fall 2012)
The reviews of the following two Interim reports resulted in shortened terms. They are (next review date is included in parentheses):
Adheris, Inc. (fall 2010); COJM International Services Inc. (fall 2010)
Discontinuation of Accreditation Provider Status
The ACPE-accredited provider status of sixteen providers was discontinued based on their request for withdrawal. They included:
Academy for Healthcare Education; AHC Media, LLC; Association of Clinical Research Professionals; Cambria Somerset Council for Education of Health Professionals, Inc.; CME, LLC; East Tennessee State University; ELF Publications, Inc.; Managed Market Research; MEBN; Medical Education Collaborative, Inc.; Parkland Health & Hospital System; Pennwell; Prescriptions Solutions; Rite AID Corporation; Sanford School of Medicine; and Tripartite Committee on Continuing Education for Pharmacists in Wyoming
The following ACPE-accredited provider status was withdrawn:
Resource Optimization & Innovation
Opportunity for Comment
Professional Programs of Colleges and Schools of Pharmacy Scheduled for On-Site Evaluations, Academic Year 2010-2011
The programs of the colleges and schools of pharmacy listed below are to be considered for accreditation during the coming academic year. On-site evaluations have been scheduled for fall or spring terms, as noted. Opportunity is hereby given for the submission of written third-party comments concerning qualifications for preaccreditation or accreditation. Copies of the ACPE Accreditation Manual are available, upon request, by writing to ACPE, 20 North Clark Street, Suite 2500, Chicago, Illinois 60602, or through the ACPE website (www.acpe-accredit.org). Written third-party comments must be received in the ACPE office not later than August 1, 2010, for fall 2010, and November 1, 2010, for spring 2011. The procedure for considering third-party comments received by the deadlines noted above should provide treatment in a way that is fair and equitable to all parties, including opportunity for response by the colleges and schools of pharmacy prior to ACPE’s accreditation action.
Fall 2010
Ferris State University College of Pharmacy
Lake Erie College of Osteopathic Medicine School of Pharmacy
Ohio State University College of Pharmacy
Temple University School of Pharmacy
University of Arizona College of Pharmacy
University of Georgia College of Pharmacy
University of Iowa College of Pharmacy
University of Michigan College of Pharmacy
University of Texas at Austin College of Pharmacy
Wilkes University Nesbitt College of Pharmacy and Nursing School of Pharmacy
Spring 2011
Albany College of Pharmacy and Health Sciences
Belmont University School of Pharmacy
California Northstate College of Pharmacy
Chicago State University College of Pharmacy
Concordia University School of Pharmacy
D’Youville College School of Pharmacy
Hampton University School of Pharmacy
Harding University College of Pharmacy
Idaho State University College of Pharmacy
Lipscomb University College of Pharmacy
Nova Southeastern University College of Pharmacy
Pacific University School of Pharmacy
Palm Beach Atlantic University Lloyd L. Gregory School of Pharmacy
Presbyterian College School of Pharmacy
Samford University McWhorter School of Pharmacy
Southern Illinois University Edwardsville School of Pharmacy
Sullivan University College of Pharmacy
Thomas Jefferson University Jefferson College of Health Professions Jefferson School of Pharmacy
Touro University California College of Pharmacy
Touro New York College of Pharmacy
Union University School of Pharmacy
University of Arkansas for Medical Sciences College of Pharmacy
University of Houston College of Pharmacy
University of Kansas School of Pharmacy
University of Maryland Eastern Shore
University of Puerto Rico Medical Sciences Campus School of Pharmacy
University of the Sciences in Philadelphia Philadelphia College of Pharmacy
University of Toledo College of Pharmacy
Xavier University of Louisiana College of Pharmacy
Providers of Continuing Pharmacy Education Scheduled for Review for Purposes of Continued Accreditation, Year 2010-2011
The providers of continuing pharmacy education listed below are to be considered for continued accreditation during 2010-2011. Opportunity is hereby given for the submission of written third-party comments concerning qualifications for accreditation. Copies of the ACPE Standards for Continuing Pharmacy Education and the Policies and Procedure Manual: A Guide for ACPE-accredited Providers, are available, upon request, by writing to ACPE 20 North Clark Street, Suite 2500, Chicago, Illinois 60602, or through the ACPE website (www.acpe-accredit.org). Written third-party comments must be received in the Council office not later than August 1, 2010, for fall 2010, and not later than November 1, 2010, for spring 2011. The procedure for considering third-party comments received by the deadlines noted above should provide for treatment in a way that is fair and equitable to all parties, including opportunity for response by the provider prior to ACPE’s accreditation action.
Fall 2010
Academy for Continued Healthcare Learning, The
Accredo Health, Inc.
AdvancMed, LLC
AmerisourceBergen Drug Company
Center for Professional Innovation & Education, The
CME Outfitters, LLC
Comprehensive Pharmacy Services, Inc.
Drug Information Association
Educational Review Systems, Inc.
Hawaii Pharmacists Association (HPhA)
Health Insights
Imedex, LLC
Innovatix, LLC
Louisiana Pharmacists Association
Massachusetts College of Pharmacy and Health Sciences
McKesson Corporation
Memorial Sloan-Kettering Cancer Center Division of Pharmacy Services
Meniscus Educational Institute
Minnesota Pharmacists Association
New Mexico Pharmacists Association
Pharmacist's Letter Therapeutic Research Center
Pharmacists Mutual Companies
Postgraduate Institute for Medicine (PIM)
Potomac Center for Medical Education
Texas Southern University College of Pharmacy and Health Sciences
Texas Tech University Health Sciences Center School of Pharmacy
University Learning Systems, Inc.
University of Florida College of Pharmacy
VA Western New York Healthcare System
Virginia Society of Health-System Pharmacists
Wingate University School of Pharmacy
Spring 2011
Alpha Zeta Omega National Pharmaceutical Fraternity Philadelphia Alumni Chapter
Butler University College of Pharmacy
Cape Fear Valley Health System
Carl T. Hayden VAMC
Carle Foundation, The
CVS Caremark
EdSource Communications, Inc.
GNYHA Services, Inc.
Grant Downing, LLC
Institute for Continuing Healthcare Education
Korean American Pharmacists Association of U.S.A
Managed Health Care Associates, Inc.
Marshfield Clinic
MedAssets Supply Chain Systems
Nesbitt School of Pharmacy at Wilkes University
New Jersey Society of Health-System Pharmacists
Nova Southeastern University College of Pharmacy
Omnicare, Inc.
Option Care, Inc.
Pediatric Pharmacy Advocacy Group
Pharmacists Society of the State of New York
Samford University McWhorter School of Pharmacy
SciMed LLC
St. Jude Children's Research Hospital Pharmaceutical Department MS150
TRINU Corporation
University of Utah College of Pharmacy
Veritas Institute for Medical Education
West Texas Pharmacy Association
ACCREDITATION COUNCIL FOR PHARMACY EDUCATION
20 North Clark Street, Suite 2500
Chicago, IL 60602-5109
Tel: (312)664-3575
Fax: (312)664-4652
www.acpe-accredit.org
ACPE was founded in 1932 as The American Council on Pharmaceutical Education.
|
Pharmacists